Cargando…
Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction
BACKGROUND: Metabolism reprogramming is a hallmark that associates tumor growth, metastasis, progressive, and poor prognosis. However, the metabolism-related molecular patterns and mechanism in clear cell renal cell carcinoma (ccRCC) remain unclear. Herein, the purpose of this study was to identify...
Autores principales: | Tai, Rongfen, Leng, Jinjun, Li, Wei, Wu, Yuerong, Yang, Junfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503121/ https://www.ncbi.nlm.nih.gov/pubmed/37715154 http://dx.doi.org/10.1186/s12894-023-01317-3 |
Ejemplares similares
-
Metabolic reprogramming of clear cell renal cell carcinoma
por: Zhu, Haiyan, et al.
Publicado: (2023) -
Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019) -
Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021) -
Computational construction of TME‐related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma
por: Zhou, Libin, et al.
Publicado: (2022) -
Identification of a Glucose Metabolism-related Signature for prediction of Clinical Prognosis in Clear Cell Renal Cell Carcinoma
por: Wang, Sheng, et al.
Publicado: (2020)